Lenzings, Heiligenkreuz

Lenzing's Heiligenkreuz Deadline Is the Test That Counts, Not the Number of Bids

Published on 11/20/2026 at 20:31 | Editorial boerse-global.de
Lenzing weighs non-binding Heiligenkreuz offers against a EUR 27 million Alabama fibre expansion as Berenberg cuts its target to EUR 13.50.
Lenzing's Heiligenkreuz Deadline Is the Test That Counts, Not the Number of Bids Illustration mit AI erstellt.

Lenzing has a habit of presenting investors with two clocks running at different speeds. One is ticking toward the end of 2026, when the company aims to establish whether a viable sale of its Heiligenkreuz site can be struck. The other measures something slower and less visible: whether the specialty-fibre expansion at Mobile, Alabama, can lift or at least hold the group's underlying profitability. Confusing the two would be a mistake.

The shares came under pressure as the week closed, shedding 4.0% on Friday evening and sitting 13% lower over a seven-day stretch. Earlier in the session the stock had been down 2.9%. Berenberg gave the market its cue on Thursday, trimming its price target to EUR 13.50 from EUR 17.00 while keeping a "Hold" rating. The broker folded a EUR 136 million impairment covering both Grimsby and Heiligenkreuz into its 2026 earnings estimate — a charge that touches two sites and therefore cannot be pinned on Heiligenkreuz alone, nor read as a guide to what a sale of that plant might fetch.

A voting-rights filing that says less than it seems

Lenzing corrected a voting-rights notification on Thursday. The aggregate position reported by Goldman Sachs fell to 4.90% from 5.86%. The revision draws a line between ownership and the exercise of votes: NN Group N.V. is the legal owner of the shares in question, while Goldman Sachs exercises the voting rights attached to them. A change in the shareholder base cannot be inferred from the lower aggregate figure on its own.

What actually matters for the valuation between now and year-end is a different question entirely — whether Lenzing can find an economically sustainable exit for Heiligenkreuz. The notification settles how a stake is attributed. The site decision determines whether the planned closure goes ahead.

Should investors sell immediately? Or is it worth buying Lenzing?

Bids on the table, but none of them binding

Lenzing said last week that it is reviewing several non-binding purchase offers. The count of interested parties is not the point. What counts is whether any of those offers can be converted into a sale that makes economic sense. While they remain non-binding, a disposal cannot be booked as relief.

The first nine months of 2026 show how much the restructuring distorts the picture. Revenue came in at EUR 1.93 billion, with an adjusted EBITDA margin of 18.3% — a measure of operating earning power that strips out one-off items. Adjusted EBITDA reached EUR 353 million. Reported EBITDA, however, was EUR 316.4 million, dragged down by EUR 36.6 million in one-offs tied to restructuring measures. That gap is why the unadjusted figure deserves equal attention: the site review is as much about earnings quality as about strategy. A workable sale would be tangible progress, but no proof that every restructuring charge is about to disappear.

Alabama runs on its own track

Separately, Lenzing announced last week that it will invest EUR 27 million in expanding specialty-fibre capacity for nonwovens at Mobile, Alabama. The outlay forms part of a broader EUR 50 million investment programme for the nonwovens business, announced on 12 November. It is a standalone project. It does not substitute for a workable solution at Heiligenkreuz, though it does show the company adding capacity elsewhere while the site review grinds on.

For investors, the question is whether that extra capacity can be sold at remunerative terms. More volume alone would not be a sufficient signal. The adjusted margin is the yardstick: if it holds or climbs in later reports, that would be a positive sign for group earning power during the overhaul — though such a development could not simply be credited to Mobile. Conversely, a sale at Heiligenkreuz would not by itself justify expecting a bigger earnings contribution from the specialty-fibre build-out. The two projects must be judged against different results.

The less comfortable path

Should none of the offers prove economically viable, the closure is slated for the end of the first quarter of 2027, according to Der Standard. A stack of bids offers no protection against that outcome; non-binding interest alone does not alter the timetable.

In the favourable scenario, the review produces a sustainable sale, and if that sale is completed, the closure earmarked for the alternative case would no longer be the governing path. The immediate benefit would be clarity on the site's future. How much a sale would contribute economically would depend on its terms.

Lenzing at a turning point? This analysis reveals what investors need to know now.

The reverse scenario is where margin pressure bites. If no sale materialises and the added capacity at Mobile cannot be utilised at adequate terms, the adjusted margin could soften even as Lenzing ships more specialty fibres. Announcing an investment says nothing yet about utilisation or returns. A decline in the adjusted margin would therefore be the more immediate warning signal for the operating business.

What the next data point can settle

By the end of 2026, according to Der Standard, it should be clear whether a viable sale is possible. That is the next concrete checkpoint — not a date for a deal already agreed. If a workable solution emerges, everything hinges on whether the offer becomes a binding agreement. If the search fails, the planned closure moves to centre stage.

For shareholders, the distinction comes down to which assumption the next step makes more robust. While Lenzing reviews non-binding offers, a sale remains an option. Only a sustainable agreement would allow investors to assess concrete disposal terms in place of a possible shutdown. Whether the Alabama expansion strengthens earning power, meanwhile, has to show up in the numbers.

Ad

Lenzing Stock: New Analysis - 20 November

Fresh Lenzing information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Lenzing analysis...

Disclaimer...
en | AT0000644505 | LENZINGS | boerse | 70541040 |